News Sentiment

REGN34 sentiment intelligence

Regeneron Pharmaceuticals, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 53 Balanced news tone 19 relevant articles
Exchange SAO Brazil
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 56.58 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

81/100 classification confidence.

Company focus 19

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-0.0% over one week, +8.8% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

Cantor Fitzgerald reiterates Overweight on Regeneron stock

Market Reaction

Balanced read

52/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 81/100 classification
One-week reaction 0.0% Price digesting
Trend fit Trend inactive 8.8% over four weeks
Fair value -18.5% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 4
Neutral 14
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 19
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Investing.com 10
Barchart.com 3
PR Newswire 1
Proactive financial news 1
Market source 1
Reuters 1
Regeneron 1
GuruFocus 1

Event Lens

What the news is about

Classified themes
Market update 12
Earnings 3
Analyst action 3
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-19 of 19
Proactive financial news Direct company coverage

Regeneron shares slide despite Q1 beat

Tone
Positive 66/100
Event
Market update
Published
29 Apr 2026 07:00
Source
Proactive financial news